The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted unanimously 13 August in favor of administering a third Pfizer Inc. or Moderna, Inc. COVID-19 mRNA vaccine in immunocompromised people, barely 12 hours after the Food and Drug Administration amended the products' emergency use authorization.
The CDC’s recommendations – signed by Director Rochelle Walensky a few hours after the ACIP vote – flesh out in...







